Upload
loui-maui
View
223
Download
0
Embed Size (px)
Citation preview
8/13/2019 BREAST CA Case Study
1/31
St. Paul Hospital Cavite, Inc.
Burol II, City of Dasmarinas, Cavite
POST-GRADUATE CLINICAL NURSE TRAINING PROGRAM
CASE STUDY:
BREAST CANCER STAGE IV
By:
Abatay, Joeven M.
Calagui, Allan R.
Inot, Jury Ann Elizabeth P.
Malapo, Lara Danica P.
8/13/2019 BREAST CA Case Study
2/31
OVERVIEW OF THE DISEASE
Breast cancer is an uncontrolled growth of breast cells.
Cancer occurs as a result of mutations, or abnormal changes, in the genes responsible for
regulating the growth of cells and keeping them healthy. The genes are in each cells nucleus,
which acts as the control room of each cell. Normally, the cells in our bodies replace
themselves through an orderly process of cell growth: healthy new cells take over as old ones
die out. But over time, mutations can turn on certain genes and turn off others in a cell.
That changed cell gains the ability to keep dividing without control or order, producing more
cells just like it and forming a tumor.
A tumor can be benign (not dangerous to health) or malignant (has the potential to be
dangerous). Benign tumors are not considered cancerous: their cells are close to normal in
appearance, they grow slowly, and they do not invade nearby tissues or spread to other parts
of the body. Malignant tumors are cancerous. Left unchecked, malignant cells eventually can
spread beyond the original tumor to other parts of the body.
The term breast cancer refers to a malignant tumor that has developed from cells in
the breast. Usually breast cancer either begins in the cells of the lobules, which are the milk- producing glands, or the ducts, the passages that drain milk from the lobules to the nipple.
Less commonly, breast cancer can begin in the stromal tissues, which include the fatty and
fibrous connective tissues of the breast.
Over time, cancer cells can invade nearby healthy breast tissue and make their way into the
underarm lymph nodes, small organs that filter out foreign substances in the body. If cancer
cells get into the lymph nodes, they then have a pathway into other parts of the body. The
breast cancers stage refers to how far the cancer cells have spread beyond the original tumor.
Breast cancer is always caused by a genetic abnormality (a mistake in the genetic material).
However, only 5-10% of cancers are due to an abnormality inherited from your mother or
father. Instead, 85-90% of breast cancers are due to genetic abnormalities that happen as a
result of the aging process and the wear and tear of life in general.
Developing breast cancer is not your or anyone's fault. Feeling guilty, or telling yourself that
breast cancer happened because of something you or anyone else did, is not productive.
8/13/2019 BREAST CA Case Study
3/31
There are three ways that cancer spreads in the body.
Cancer can spread through tissue, the lymph system, and the blood:
Tissue. The cancer spreads from where it began by growing into nearby areas.
Lymph system. The cancer spreads from where it began by getting into the lymph
system. The cancer travels through the lymph vessels to other parts of the body.
Blood. The cancer spreads from where it began by getting into the blood. The cancer
travels through the blood vessels to other parts of the body.
RISK FACTORS
MODIFIABLE
Weight. Being overweight is associated with increased risk of breast cancer, especially for
women after menopause. Fat tissue is the bodys main source of estrogen after menopause,
when the ovaries stop producing the hormone. Having more fat tissue means having higher
estrogen levels, which can increase breast cancer risk.
Diet. Diet is a suspected risk factor for many types of cancer, including breast cancer, but
studies have yet to show for sure which types of foods increase risk. Its a good idea to
restrict sources of red meat and other animal fats (including dairy fat in cheese, milk, and ice
cream), because they may contain hormones, other growth factors, antibiotics, and pesticides.
Some researchers believe that eating too much cholesterol and other fats are risk factors for
cancer, and studies show that eating a lot of red and/or processed meats is associated with a
higher risk of breast cancer. A low-fat diet rich in fruits and vegetables is generallyrecommended.
Exercise. Evidence is growing that exercise can reduce breast cancer risk. The American
Cancer Society recommends engaging in 45-60 minutes of physical exercise 5 or more days a
week.
http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46683&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45764&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=270735&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=269462&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45020&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45020&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=269462&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=270735&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45764&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46683&version=Patient&language=English8/13/2019 BREAST CA Case Study
4/31
Alcohol consumption. Studies have shown that breast cancer risk increases with the amount
of alcohol a woman drinks. Alcohol can limit your livers ability to control blood lev els of
the hormone estrogen, which in turn can increase risk.
Smoking. Smoking is associated with a small increase in breast cancer risk.
Exposure to estrogen. Because the female hormone estrogen stimulates breast cell growth,
exposure to estrogen over long periods of time, without any breaks, can increase the risk of
breast cancer. Some of these risk factors are under your control, such as:
taking combined hormone replacement therapy (estrogen and progesterone; HRT) for
several years or more, or taking estrogen alone for more than 10 years
being overweight
regularly drinking alcohol
Recent oral contraceptive use. Using oral contraceptives (birth control pills) appears to
slightly increase a womans risk for breast cancer, but only for a limited period of ti me.
Women who stopped using oral contraceptives more than 10 years ago do not appear to have
any increased breast cancer risk.
Stress and anxiety. There is no clear proof that stress and anxiety can increase breast cancer
risk. However, anything you can do to reduce your stress and to enhance your comfort, joy,
and satisfaction can have a major effect on your quality of life. So- called mindful measures
(such as meditation, yoga, visualization exercises, and prayer) may be valuable additions to
your daily or weekly routine. Some research suggests that these practices can strengthen the
immune system.
NON- MODIFIABLE
Gender. Being a woman is the most significant risk factor for developing breast cancer.
Although men can get breast cancer, too, womens breast cells are constantly changing and
growing, mainly due to the activity of the female hormones estrogen and progesterone. This
activity puts them at much greater risk for breast cancer.
8/13/2019 BREAST CA Case Study
5/31
Age. Simply growing older is the second biggest risk factor for breast cancer. From age 30 to
39, the risk is 1 in 227, or .44%. That jumps to 1 in 28, or just under 4%, by the time you are
in your 60s.
Family history of breast cancer. If you have a first-degree relative (mother, daughter, sister)
who has had breast cancer, or you have multiple relatives affected by breast or ovarian cancer
(especially before they turned age 50), you could be at higher risk of getting breast cancer.
Personal history of breast cancer. If you have already been diagnosed with breast cancer,
your risk of developing it again, either in the same breast or the other breast, is higher than if
you never had the disease.
Race. White women are slightly more likely to develop breast cancer than are African
American women. Asian, Hispanic, and Native American women have a lower risk of
developing and dying from breast cancer.
Radiation therapy to the chest. Having radiation therapy to the chest area as a child or
young adult as treatment for another cancer significantly increases breast cancer risk. The
increase in risk seems to be highest if the radiation was given while the breasts were stilldeveloping (during the teen years).
Breast cellular changes. Unusual changes in breast cells found during a breast biopsy
(removal of suspicious tissue for examination under a microscope) can be a risk factor for
developing breast cancer. These changes include overgrowth of cells (called hyperplasia) or
abnormal (atypical) appearance.
Exposure to estrogen. Because the female hormone estrogen stimulates breast cell growth,
exposure to estrogen over long periods of time, without any breaks, can increase the risk of
breast cancer. Some of these risk factors are not under your control, such as:
starting menstruation (monthly periods) at a young age (before age 12)
going through menopause (end of monthly cycles) at a late age (after 55)
exposure to estrogens in the environment (such as hormones in meat or pesticides such as
DDT, which produce estrogen-like substances when broken down by the body)
8/13/2019 BREAST CA Case Study
6/31
Pregnancy and breastfeeding. Pregnancy and breastfeeding reduce the overall number of
menstrual cycles in a womans lifetime, and this appears to reduce future breast cancer risk.
Women who have never had a full-term pregnancy, or had their first full-term pregnancy
after age 30, have an increased risk of breast cancer. For women who do have children,
breastfeeding may slightly lower their breast cancer risk, especially if they continue
breastfeeding for 1 1/2 to 2 years. For many women, however, breastfeeding for this long is
neither possible nor practical.
DES exposure. Women who took a medication called diethylstilbestrol (DES), used to
prevent miscarriage from the 1940s through the 1960s, have a slightly increased risk of breast
cancer. Women whose mothers took DES during pregnancy may have a higher risk of breast
cancer as well.
SYMPTOMS
Early breast cancer usually does not cause symptoms. This is why regular breast exams are
important. As the cancer grows, symptoms may include:
Breast lump or lump in the armpit that is hard, has uneven edges, and usually does not
hurt Change in the size, shape, or feel of the breast or nipple -- for example, you may have
redness, dimpling, or puckering that looks like the skin of an orange
Fluid coming from the nipple -- may be bloody, clear to yellow, green, and look like
pus
Men can get breast cancer, too. Symptoms include breast lump and breast pain and
tenderness.
Symptoms of advanced breast cancer may include:
Bone pain Breast pain or discomfort Skin ulcers Swelling of in the armpit (next to the breast with cancer) Weight loss
http://www.nlm.nih.gov/medlineplus/ency/article/003155.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003155.htm8/13/2019 BREAST CA Case Study
7/31
Stage IV Breast Cancer
Stage IV breast cancer. The cancer has spread to other parts of the body, most the
bones, lungs, liver, or brain.often
In stage IV, cancer has spread to other organs of the body, most often the
bones, lungs, liver, or brain.
Stage IV and metastatic breast cancer
Treatment of stage IV or metastatic breast cancer may include the following:
Hormone therapy and/or chemotherapy with or without trastuzumab. Monoclonal antibody therapy with trastuzumab and pertuzumab combined
with chemotherapy.
Antibody-drug conjugate therapy with ado-trastuzumab emtansine.
Tyrosine kinase inhibitor therapy with lapatinib combined with capecitabine.
Radiation therapy and/or surgery for relief of pain and other symptoms.
Bisphosphonate drugs to reduce bone disease and pain when cancer has
spread to the bone.
Clinical trials testing new chemotherapy and/or hormone therapy.
Clinical trials of new combinations of treatments, including targeted therapy,
hormone therapy, and chemotherapy.
Clinical trials testing other treatments, including high-dose
chemotherapy with stem cell transplant.
TREATMENTS
Surgery
Most patients with breast cancer have surgery to remove the cancer from the breast. Some of
the lymph nodes under the arm are usually taken out and looked at under a microscope to see
if they contain cancer cells.
http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45162&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45333&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=257523&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=270740&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46312&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45162&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44058&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=444971&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45110&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45214&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45439&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46066&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44737&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=340934&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=747093&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44833&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44833&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=390335&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45565&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44971&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45570&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45022&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44817&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=348921&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45961&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=270742&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=346522&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=346522&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46695&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45570&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45762&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=638184&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46476&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46476&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=638184&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45762&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45570&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46695&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=346522&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=346522&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=270742&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45961&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=348921&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44817&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45022&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45570&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44971&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45565&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=390335&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44833&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=747093&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=340934&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44737&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46066&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45439&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45214&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45110&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=444971&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44058&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45162&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46312&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=270740&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=257523&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45333&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45162&version=Patient&language=English8/13/2019 BREAST CA Case Study
8/31
Breast-conserving surgery, an operation to remove the cancer but not the breast itself,
includes the following:
Lumpectomy: Surgery to remove a tumor (lump) and a small amount of
normal tissue around it.
Partial mastectomy: Surgery to remove the part of the breast that has cancer
and some normal tissue around it. The lining over the chest muscles below
the cancer may also be removed. This procedure is also called a segmental
mastectomy.
Breast-conserving surgery. Dotted lines show the area containing the tumor that is
removed and some of the lymph nodes that may be removed.
Patients who are treated with breast-conserving surgery may also have some of the
lymph nodes under the arm removed for biopsy. This procedure is called lymph node
dissection. It may be done at the same time as the breast-conserving surgery or after. Lymph
node dissection is done through a separate incision.
Other types of surgery include the following:
Total mastectomy: Surgery to remove the whole breast that has cancer. This
procedure is also called a simple mastectomy. Some of the lymph nodes
under the arm may be removed for biopsy at the same time as the breast
surgery or after. This is done through a separate incision.
Total (simple) mastectomy. The dotted line shows where the
entire breast is removed. Some lymph nodes under the arm may also be
removed. Modified radical mastectomy: Surgery to remove the whole breast that has
cancer, many of the lymph nodes under the arm, the lining over the chest
muscles, and sometimes, part of the chest wall muscles.
Modified radical mastectomy. The dotted line shows where the entire
breast and some lymph nodes are removed. Part of the chest wall muscle may
also be removed.
http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45626&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45758&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46634&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46683&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45105&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46575&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46575&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45164&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44435&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44435&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46353&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46620&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46285&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44996&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44996&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46285&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46620&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46353&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44435&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44435&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45164&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46575&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46575&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45105&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46683&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46634&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45758&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45626&version=Patient&language=English8/13/2019 BREAST CA Case Study
9/31
Chemotherapy may be given before surgery to remove the tumor. When given before
surgery, chemotherapy will shrink the tumor and reduce the amount of tissue that needs to be
removed during surgery. Treatment given before surgery is called neoadjuvant therapy.
Even if the doctor removes all the cancer that can be seen at the time of the surgery,
some patients may be given radiation therapy, chemotherapy, or hormone therapy after
surgery to kill any cancer cells that are left. Treatment given after the surgery, to lower the
risk that the cancer will come back, is called adjuvant therapy.
If a patient is going to have a mastectomy, breast reconstruction (surgery to rebuild a
breasts shape after a mastectomy) may be considered. Breast reconstruction may be done at
the time of the mastectomy or at a future time. The reconstructed breast may be made withthe patients own (nonbreast) tissue or by using implants filled with saline or silicone gel.
Sentinel lymph node biopsy followed by surgery
Sentinel lymph node biopsy is the removal of the sentinel lymph node during surgery.
The sentinel lymph node is the first lymph node to receive lymphatic drainage from a tumor.
It is the first lymph node the cancer is likely to spread to from the tumor.
A radioactive substance and/or blue dye is injected near the tumor. The substance or dyeflows through the lymph ducts to the lymph nodes. The first lymph node to receive the
substance or dye is removed. A pathologist views the tissue under amicroscope to look for
cancer cells. If cancer cells are not found, it may not be necessary to remove more lymph
nodes. After the sentinel lymph node biopsy, the surgeon removes the tumor (breast-
conserving surgery or mastectomy).
Sentinel lymph node biopsy of the breast. A radioactive substance and/or blue dye is
injected near the tumor (first panel). The injected material is detected visually and/or with a
probe that detects radioactivity (middle panel). The sentinel nodes (the first lymph nodes to
take up the material) are removed and checked for cancer cells (last panel).
Radiation therapy
Radiation therapy is a cancer treatment that uses high-energy x-rays or other types
of radiation to kill cancer cells or keep them from growing. There are two types of radiation
therapy. External radiationt herapy uses a machine outside the body to send radiation toward
http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45214&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45800&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44971&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45110&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45587&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45777&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46492&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44676&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46152&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44725&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46712&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45876&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45760&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46550&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=409764&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44678&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46441&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46244&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=638184&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44306&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45944&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45072&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46686&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46686&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45072&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45944&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44306&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=638184&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46244&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46441&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44678&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=409764&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46550&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45760&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45876&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46712&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44725&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46152&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44676&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46492&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45777&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45587&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45110&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44971&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45800&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45214&version=Patient&language=English8/13/2019 BREAST CA Case Study
10/31
the cancer. Internal radiationt herapy uses a radioactive substance sealed in needles, seeds,
wires, or catheters that are placed directly into or near the cancer. The way the radiation
therapy is given depends on the type and stage of the cancer being treated.
Chemotherapy
Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells,
either by killing the cells or by stopping them from dividing. When chemotherapy is taken by
mouth or injected into avein or muscle, the drugs enter the bloodstream and can reach cancer
cells throughout the body (systemic chemotherapy) . When chemotherapy is placed directly
into the cerebrospinal fluid, an organ, or a body cavity such as the abdomen, the drugs mainly
affect cancer cells in those areas (regional chemotherapy) . The way the chemotherapy isgiven depends on the type and stage of the cancer being treated.
Hormone therapy
Hormone therapy is a cancer treatment that removes hormones or blocks their action
and stops cancer cells from growing. Hormones are substances made by glands in the body
and circulated in the bloodstream. Some hormones can cause certain cancers to grow. If tests
show that the cancer cells have places where hormones can attach (receptors) , drugs, surgery,or radiation therapy is used to reduce the production of hormones or block them from
working. The hormone estrogen, which makes some breast cancers grow, is made mainly by
the ovaries. Treatment to stop the ovaries from making estrogen is called ovarian ablation.
Hormone therapy with tamoxifen is often given to patients with early stages of breast
cancer and those with metastatic breast cancer (cancer that has spread to other parts of the
body). Hormone therapy with tamoxifen or estrogens can act on cells all over the body and
may increase the chance of developing endometrial cancer. Women taking tamoxifen should
have a pelvic exam every year to look for any signs of cancer. Any vaginal bleeding, other
than menstrual bleeding, should be reported to a doctor as soon as possible.
Hormone therapy with an aromatase inhibitor is given to
some postmenopausal women who have hormone-dependent breast cancer. Hormone-
dependent breast cancer needs the hormone estrogent o grow. Aromatase inhibitors decrease
http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46345&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=257219&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45637&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45885&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=348921&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=476471&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=301626&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46483&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=257523&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=463703&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45070&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46559&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45110&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45713&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46386&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44958&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46076&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46687&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45811&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45576&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=446564&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=446564&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44058&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45044&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45087&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44308&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45784&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44232&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45269&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46076&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46076&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45269&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44232&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45784&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44308&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45087&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45044&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44058&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=446564&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=446564&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45576&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45811&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46687&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46076&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44958&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46386&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45713&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45110&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46559&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45070&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=463703&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=257523&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46483&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=301626&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=476471&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=348921&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45885&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45637&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=257219&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46345&version=Patient&language=English8/13/2019 BREAST CA Case Study
11/31
the body's estrogen by blocking an enzyme called aromatase from turning androgen into
estrogen.
For the treatment of early stage breast cancer, certain aromatase inhibitors may be
used as adjuvant therapy instead of tamoxifen or after 2 or more years of tamoxifen. For the
treatment of metastatic breast cancer, aromatase inhibitors are being tested in clinical trials to
compare them to hormone therapy with tamoxifen.
Targeted therapy
Targeted therapy is a type of treatment that uses drugs or other substances to identify
and attack specific cancer cells without harming normal cells. Monoclonal
antibodies and tyrosine kinase inhibitors are two types of targeted therapies used in the
treatment of breast cancer. PARP inhibitors are a type of targeted therapy being studied for
the treatment of triple-negative breast cancer.
Monoclonal antibody therapy is a cancer treatment that uses antibodies made in the
laboratory, from a single type of immune system cell. These antibodies can identify
substances on cancer cells or normal substances that may help cancer cells grow. The
antibodies attach to the substances and kill the cancer cells, block their growth, or keep themfrom spreading. Monoclonal antibodies are given by infusion. They may be used alone or to
carry drugs, toxins, or radioactive material directly to cancer cells. Monoclonal antibodies
may be used in combination with chemotherapy as adjuvant therapy.
Trastuzumab is a monoclonal antibody that blocks the effects of the growth
factor protein HER2, which sends growth signals to breast cancer cells. About one-fourth of
patients with breast cancer have tumors that may be treated with trastuzumab combined with
chemotherapy.
Pertuzumab is a monoclonal antibody that may be combined with trastuzumab and
chemotherapy to treat breast cancer. It may be used to treat certain patients with HER2-
positive breast cancer that ha smetastasized (spread to other parts of the body).
Ado-trastuzumab emtansine is a monoclonal antibody linked to an anticancer drug.
This is called an antibody-drug conjugate. It is used to treat HER2-positive breast cancer that
has spread to other parts of the body or recurred (come back).
http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46081&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45592&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44058&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=270742&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46066&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46066&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44833&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=660869&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=639916&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44737&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44918&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46356&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45738&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46622&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45439&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45705&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45705&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46092&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44945&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=340934&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=737998&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=737998&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46283&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=747093&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46556&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46556&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=747093&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46283&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=737998&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=737998&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=340934&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44945&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46092&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45705&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45705&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45439&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46622&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45738&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46356&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44918&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44737&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=639916&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=660869&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44833&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46066&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46066&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=270742&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44058&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45592&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46081&version=Patient&language=English8/13/2019 BREAST CA Case Study
12/31
Tyrosine kinase inhibitors are targeted therapy drugs that block signals needed for
tumors to grow. Tyrosine kinase inhibitors may be used with other anticancer drugs as
adjuvant therapy.
Lapatinib is a tyrosine kinase inhibitor that blocks the effects of the HER2 protein and
other proteinsi nside tumor cells. It may be used with other drugs to treat patients with HER2-
positive breast cancer that has progressed after treatment with trastuzumab.
PARP inhibitors are a type of targeted therapy that block DNA repair and may cause
cancer cells to die. PARP inhibitor therapy is being studied for the treatment of triple-
negative breast cancer.
High-dose chemotherapy with stem cell transplant
High-dose chemotherapy with stem cell transplant is a way of giving high doses of
chemotherapy and replacing blood -forming cells destroyed by the cancer treatment. Stem
cells (immature blood cells) are removed from the blood or bone marrow of the patient or
a donor and are frozen and stored. After the chemotherapy is completed, the stored stem cells
are thawed and given back to the patient through an infusion. These reinfused stem cells grow
into (and restore) the bodys blood cells.
Studies have shown that high-dose chemotherapy followed by stem cell transplant
does not work better than standard chemotherapy in the treatment of breast cancer. Doctors
have decided that, for now, high-dose chemotherapy should be tested only in clinical trials.
Before taking part in such a trial, women should talk with their doctors about the serious side
effects, including death, that may be caused by high-dose chemotherapy.
Stage IV and metastatic breast cancer
Treatment of stage IV or metastatic breast cancer may include the following:
Hormone therapy and/or chemotherapy with or without trastuzumab.
Monoclonal antibody therapy with trastuzumab and pertuzumab combined
with chemotherapy.
Antibody-drug conjugate therapy with ado-trastuzumab emtansine.
http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=390335&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46092&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44078&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45671&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=346522&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46695&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44664&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=270735&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46598&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46598&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45622&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=643010&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46580&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46580&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45162&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44058&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=444971&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45110&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45214&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45439&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46066&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44737&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=340934&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=747093&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=747093&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=340934&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44737&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46066&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45439&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45214&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45110&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=444971&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44058&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45162&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46580&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46580&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=643010&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45622&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46598&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46598&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=270735&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44664&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46695&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=346522&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45671&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44078&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46092&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=390335&version=Patient&language=English8/13/2019 BREAST CA Case Study
13/31
Tyrosine kinase inhibitor therapy with lapatinib combined with capecitabine.
Radiation therapy and/or surgery for relief of pain and other symptoms.
Bisphosphonate drugs to reduce bone disease and pain when cancer has
spread to the bone.
Clinical trials testing new chemotherapy and/or hormone therapy.
Clinical trials of new combinations of treatments, including targeted therapy,
hormone therapy, and chemotherapy.
Clinical trials testing other treatments, including high-dose
chemotherapy with stem cell transplant.
INCIDENCE IN THE PHILIPPINES
October is Breast Cancer Awareness Month, and many countries in the world, including the
Philippines, are planning a set of activities in line with this event. Everyone is encouraged to
participate by helping to raise funds for research and indigent patients, volunteering to help
those battling the disease in any way you can or simply educating yourself on breast cancer
prevention and treatment.
The Philippines is at the center of the fight against breast cancer in Asia. The country has the
highest incidence of breast cancer in the continent and an estimated 3 out of 100 Filipino
women will contract the disease before age 75; 1 out of 100 will die before age 75, according
to the Philippine Society of Medical Oncology in 2012. This complements the Department of
Health and Philippine Cancer Society, Inc. report, which states that breast cancer is the most
common cancer in the country, comprising 16 percent of the 80,000 new cancer cases in2010.
http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44833&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44833&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=390335&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45565&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44971&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45570&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45022&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44817&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=348921&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45961&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=270742&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=346522&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=346522&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46695&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46695&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=346522&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=346522&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=270742&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45961&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=348921&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44817&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45022&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45570&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44971&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45565&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=390335&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44833&version=Patient&language=English8/13/2019 BREAST CA Case Study
14/31
PATIENTS PROFILE
Name : Mrs. L.B.
Address : Burol I, Dasmarinas, Cavite
Birthdate : November 12, 1962
Age : 51
Religion : Iglesia ni Cristo
Nationality : Filipino
Occupation : Housewife
Date of admission: December 01, 2013
Time of admission : 7:20 pm
Chief Complaint : Loss of appetite
Attending Physician : Dr. Manansala
Admitting Diagnosis : Breast Cancer
Final Diagnosis: Breast Cancer Stage 4
PAST HEALTH HISTORY
Patient Mrs.L.B cannot remember if she received complete immunizations for thedifferent childhood illnesses. When asked about the childhood illnesses she had experienced,
patient Mrs.L.B said that she had chicken pox and mumps during her elementary years. She
has no known allergies to food and drugs and has no history of asthma, accidents or falls.
FAMILIAL HISTORY:
There is no history of cancer on her family.
HISTORY OF PRESENT ILLLNESS (CANCER)
According to Mrs.L.B, she first felt a lump in her left breast (upper quadrant)
sometime on June 2012 while she was taking a bath. She first ignored this since she thought it
was nothing to be worried about because it was not painful after all. Hindi ko na pinansin
kasi akala ko wala lang yun and that it will go away by itself , she verbalized.
It was in May 2013 when she noticed that the lump was getting bigger and she noticed
redness and dimpling in the area where the lump was felt. Parang pumaloob yung skin kodito (pointing to her breast), parang dimples, na wala naman noong una kong napansin last
8/13/2019 BREAST CA Case Study
15/31
year , she verbalized. She mentioned this to her daughter, then later she was advised to
consult and went to a Private Hospital and diagnosed of a Breast Cancer Stage 4.
Her latest confinement on December 1, 2013 was due to the body weakness she was
experiencing for almost 3 days already prior to admission accompanied by loss of appetite,
cough and loss of appetite. Mabilis akong manghina at I have difficulty of breathing at wala
pa akong ganang kumain. as she verbalized.
GORDONS FUNCTIONAL ASSESSMENT
A. Health Perception/ Health Management Pattern
The patient describes health as being free of any common illness such as
cough, colds and fever. They do self-medication treatments during the event of
common sickness and only visit the doctor if the illness will not be managed by these
medications from drug stores.
B. Nutritional/ Metabolic Pattern
Last August of this year that a loss of appetite was noted and that precipitated
the 1 st hospitalization of the patient to another hospital for the management of
weakness and loss of appetite. There were no mentioned set of meals offered on the
previous hospitalization. During her hospitalization in our institution loss of appetite
is also a problem and patient refused to insert an NGT for her nutrition. But according
to the patient and her eldest daughter before the illness occurred, the patient and her
family usually eats 3 to 4 times a day and would usually have pizza, pasta and breads
for all of their meals. The patient usually drinks 5-6 glasses of water per day.
C. Elimination Before hospitalization, the patient urinates 4-5 times a day, reddish in color with
moderate amount and with difficulty in urinating, she complains of pain during
urination. She defecates 2 times a day and described the stool as light brown,
semi-formed and moderate in amount.
During the hospitalization, the patient urinates 3-4 times a day, yellowish in color
and small in amount. Sometimes she defecates usually in the morning but there isan instance that she cannot defecate the whole day.
8/13/2019 BREAST CA Case Study
16/31
D. Activity-Exercise Pattern Before hospitalization, the patient do house hold chores like washing the dishes,
cleaning the house, washing the clothes as her only form of exercise.
During hospitalization, the patient is lying in her bed because of her difficulty of
breathing, body weakness, enlargement of the abdomen and edematous lower
extremities and so she has to be assisted with her activities of daily living.
E. Sleep-Rest Pattern Before hospitalization, the patient sleeps 6-7 hours every night. She usually
sleeps at 11 oclock in the evening and wakes up at 7 oclock in the morning.
According to her, she takes a rest whenever she feels tired from any activity that
she conducts within the day.
During hospitalization, the patient is on bed all the time due to body weakness.
Then wakes up when she feels something painful or any discomforts.
F.
Cognitive-Perceptual PatternThe patient is conscious and coherent and oriented time, where she is and the
persons around her. The memory is still intact. She is a college graduate.
G. Self-Perception/ Self Concept
She considers herself a responsible person though a simple one. She is loving
and understanding to family and friends.
H. Role-Relationship Pattern Prior hospitalization, the patient has a strong bond with her family. She is loved
by her family. Her husband is a Seaman and sees to it that whenever her husband
comes back to the Philippines they will have a vacation time for the whole family.
During Hospitalization: Family bonding is still intact. But the role of being a
mother to her children is not that good due to her present condition.
I. Sexual Reproductive
8/13/2019 BREAST CA Case Study
17/31
8/13/2019 BREAST CA Case Study
18/31
ANATOMY AND PHYSIOLOGY OF THE BREAST
Women and men both have breasts, but women have more breast tissue than men. Each
breast lies over a muscle of the chest called the pectoral muscle. The female breast covers a
fairly large area. It extends from just below the collarbone (clavicle), to the armpit (axilla)
and across to the breastbone (sternum).
Structure
The breast is a mass of glandular, fatty and connective tissue. The breast is made up of:
lobules glands that produce milk
ducts tubes that carry milk from the lobules to the nipple
fatty and connective tissue surrounds and protects the ducts and lobules and givesshape to the breast
areola the pink or brown, circular area around the nipple that contains small sweat
glands, which release (secrete) moisture as a lubricant during breast-feeding
nipple the area at the centre of the areola where the milk comes out
Ligaments support the breast. They run from
the skin through the breast and attach to
muscles on the chest.
There are several major nerves in the breast
area, including nerves in the chest and arm.
There are also sensory nerves in the skin of
the chest and axilla.
8/13/2019 BREAST CA Case Study
19/31
The lymphatic system of the breast
The breast has many blood vessels and lymph vessels. Lymph vessels are thin tubes similar to
blood vessels. They collect and move lymph fluid away from the breast into small bean-
shaped masses of lymphatic tissue, called lymph nodes, in the area around the breast. Thelymph vessels and lymph nodes are part of the lymphatic system, which helps fight
infections.
The breast lymph nodes include:
supraclavicular nodes above the collarbone
infraclavicular (or subclavicular) nodes below the collarbone
axillary nodes in the armpit (axilla)
internal mammary nodes inside the chest around the breastbone (sternum)
Axillary lymph nodes
There are about 30 50 lymph nodes in the axilla. The number varies from woman to woman.
The axillary lymph nodes are divided into 3 levels according to how close they are to the
pectoral muscle on the chest:
level I (low axilla) located in the lower or bottom part of the armpit, along theoutside border of the pectoral muscle
level II (mid axilla) located in the middle part of the armpit, beneath the pectoral
muscle
level III (high axilla) located below and near the centre of the collarbone, above the
breast area and along the inside border of the pectoral muscle
http://www.cancer.ca/glossary?CCEID=9960&culture=enhttp://www.cancer.ca/glossary?CCEID=9961&culture=enhttp://www.cancer.ca/glossary?CCEID=9920&culture=enhttp://www.cancer.ca/glossary?CCEID=9920&culture=enhttp://www.cancer.ca/glossary?CCEID=9961&culture=enhttp://www.cancer.ca/glossary?CCEID=9960&culture=en8/13/2019 BREAST CA Case Study
20/31
When breast cancer spreads, it usually
goes to level I lymph nodes first, to level
II next and then to level III.
Breast development
Breast tissue changes at different times during a womans life. It changes during puberty,
during the menstrual cycle, during pregnancy and after menopause.
Female breasts do not begin growing until puberty (around 10 12 years of age). At this time,
the breasts respond to hormonal changes (mostly increased estrogen and progesterone) in the
body and begin to develop. During puberty, the breast ducts and milk glands grow. The breast
skin stretches as the breasts grow, creating a rounded appearance. Young women tend to have
denser breasts (more glandular tissue) than older women.
In older women, much of the glandular and ductal tissue is replaced with fatty tissue and
breasts become less dense. Ligaments also lose their elasticity when women age, causing the
breasts to sag.
The size and shape of womens breasts vary considerably. Some women have a large amount
of breast tissue and have larger breasts. Others have a smaller amount of tissue with little
breast fat. A womans breasts are rarely the same size. Often one breast is slightly larger or
smaller, higher or lower or shaped differently than the other.
Hormones and the breast
Estrogen is the main female hormone. It influences female sexual characteristics, such as
breast development, and it is necessary for reproduction. M ost of the estrogen in a womans
body is made by the ovaries, though a small amount is made by the adrenal glands.
8/13/2019 BREAST CA Case Study
21/31
Progesterone is the other female sex hormone made in the ovaries. Its role is to prepare the
uterus (womb) for pregnancy and the breasts for producing milk for breast-feeding
(lactation).
The breast tissues are exposed to monthly cycles of estrogen and progesterone throughout a
womans childbearing years.
In the first part of the menstrual cycle, estrogen stimulates the growth of the milk
ducts.
Progesterone takes over in the second part of a womans menstrual cycle, stimulating
the lobules.
After menopause, the monthly cycle of estrogen and progesterone end. However, the adrenal
glands continue to produce estrogen so that a woman keeps her sexual characteristics.
Function
The breasts main function is to produce, store and release milk to feed a baby. Milk is
produced in lobules throughout the breast when they are stimulated by hormones in a
womans body after giving birth. The ducts carry t he milk to the nipple. Milk passes from thenipple to the baby during breast-feeding.
8/13/2019 BREAST CA Case Study
22/31
PATHOPHYSIOLOGY OF BREAST CANCER
3.Etiology
-Idio athic-
2.Precipitating Factors> Exposure to exogenous estrogen(Oral Contraceptives)>Lifestyle (She is active and does
household chores)
1.Predisposing Factors> Age (greatest at the age of 50and beyond)> Sex 98-99% of cases occur inwomen> Menstrual Cycle (earlymenarche and late menopause)> Genetics
Stimulates development of breastducts; stimulates the replication of
damaged DNA cells
Inheritance ofmutated
BrCa1/BrCa2 genes
DNA, RNA andcellular aberrations
Mutation
Normal tumor suppressor geneinactivated
Protooncogene activated
Unregulated epithelial celldivision along ducts / lobes
A
8/13/2019 BREAST CA Case Study
23/31
Communicates with breast stromal
Stimulation of Vascular endothelial growth factor (VEGF ) pathways
Proliferation of tumorcells near rimar tumor
Venous obstruction
Venous en or ement
Invasion and adhesion oftumor cells in pectoral(deep fascia) muscles
Angiogenesis
Nourishment to primary and
adjacent tumors
Entry to cancercells in blood
circulation
Lymphaticinvolvement
Breast Dimpling /Retraction
Further Growth ofPrimary Tumor
Metastasis
B
A
8/13/2019 BREAST CA Case Study
24/31
Disruption inhematopoiesis
Erythropoiesisdisruption
Decreased RBCProduction
Low HCTAnemia
Paleness Low HgB
Disruption inLeukocyte formation
Bones
Suppressionof leukocyte production
Decreased WBC production
Leukopenia / Neutropenia
B
8/13/2019 BREAST CA Case Study
25/31
B
Kidney Liver
Splanchnic vasodilation
Portal hypertension
Decreased effective circulatory volume
Activation of renin-angiotensin-aldosterone system
Renal sodium avidity and hepatorenals ndrome
Ascites Edema of both lower
extremities
8/13/2019 BREAST CA Case Study
26/31
LABORATORY/DIAGNOSTICS EXAMINATIONS
Date: December 1, 2013
Procedure NormalValue
Result Interpretation
HEMATOLOGY
Hemoglobin 12-15gm/L
9.9 Decreased dueto due to
disruption inerythropoiesissecondary to
bone metastasisand
chemotherapyHematocrit 37-47% 31.5 Decreased due
to due todisruption inerythropoiesissecondary to
bone metastasisWBC 5-10 25.4 Severe
infectionRBC 4.2-5.4 3.8 A decrease
implies anemiaand fluidoverload
Segmenters 50-70 90 Sign ofinfection
Monocytes 2.5-8 2 NormalLymphocytes 20-40 6 Immune-
deficiency Platelet 150,000-
500,000760 Implies anemia
ClinicalChemistry
BUN 2.14-7.14
10.3 Defectivetubular
reabsorption,malnutrition
and nephrosisSerum Sodium 135-148 126 Due to ascites,
renalinsufficiency
SerumPotassium
3.5-5.3 4.8 Normal
Creatinine 45-84 71 Normal
8/13/2019 BREAST CA Case Study
27/31
Chest Xray-PA
Findings: Hazy densities are seen in the in the Right Lower Lobe
Heart Shadow is Borderline in size
The Right Hemidiaphragm is Slightly Elevated
The Left Hemidiaphragm is Slightly Intact
The Rest of the visualized Thoracic Structures are Unremarkable
Impression:
Pneumonia
Slightly Elevated Right Hemidiaphragm Subpulmonic Effusion is
Is not Ruled Out. Aright Lateral Decubitus View or Chest
Ultrasound Correlation is Recommended for further evaluation.
8/13/2019 BREAST CA Case Study
28/31
NURSING CARE PLAN
DATE/ TIME FOCUS DATA/ ACTION/ RESPONSE
December 2, 20126AM
6:15AM
F> Difficulty of Breathing D> RR: 30s,gasping, nasal flaring, and used of accessory
muscles, irritable O 2 Sat 93%,
A>Assessed for signs and symptoms of respiratory distress. AP
and ROD informed. Placed on moderate high back rest.
Changed oxygen via nasal cannula to face mask as ordered.
Encouraged to do deep breathing exercise. Advised patient to
rest.
R> RR= 23, O 2 Sat 98%, no nasal flaring, gasping and used of
accessory muscles noted. Endorsed.
8/13/2019 BREAST CA Case Study
29/31
DATE/ TIME FOCUS DATA/ ACTION/ RESPONSE
December 2, 20136AM
7AM
F> Increased in blood pressure D> Blood pressure of 160/ 100, restless, irritability noted.
A> Assessed patient condition. Promoted calm, comfortable and
safety environment. Kept well rested. Maintained activity
restrictions and assessed patient with self- care activities.
Monitored for signs and symptoms of severely elevated blood
pressure such as headache feeling of vomiting and nausea.
Monitored patient frequently. Catapress 150mcg/tab sublingual
given as ordered.
R> Reassessed patient, blood pressure of 140/ 90. Patient was
able to have rest, not irritable. Endorsed
8/13/2019 BREAST CA Case Study
30/31
DATE/ TIME FOCUS DATA/ ACTION/ RESPONSE
December 03, 20136AM
7AM
F> Anxiety D> Natatakot ako sa maaring mangyare o sa sakit ko. With a
scale of moderate anxiety. Irritability, restless, cold clammy
skin, pale in appearance noted.
A> Assessed patient general health status. Assessed level of
anxiety. Encouraged verbalization of feelings. Provided accurate
information about the situation. Encouraged therapeutic
relationship and be available to client for listening and talking.
Monitored patient frequently.
R> Patient still in a moderate anxiety due to her condition.
Endorsed.
8/13/2019 BREAST CA Case Study
31/31
REFERENCES
Books
Balita, C.E. (2008). Ultimate Learning Guide to Nursing Review. Philippines. Tri-
Mega Printing.
Burstein, H.J., Harris, J.R., & Morrow, M. Cancer of the Breast: Section 2: Malignant
Tumors of the Breast. Devita, V. T., Jr., Lawrence, T. S., & Rosenberg, S. A.
(2008). Cancer: Principles & Practice of Oncology . (8th Edition). Philadelphia:
Wolters Kluwer Health/Lippincott Williams & Wilkins. 43(2) pp. 1606-1654.
Martini, F. H., Timmons, M. J., & Tallitsch, R. B. (2009). Human Anatomy . (6th Edition).
San Francisco: Pearson Benjamin Cummings.
Wilson, B.A., Shannon, M.T., & Shields, K. (2011). Nurses Drug Guide 2011. Upper Saddle
River, NJ: Pearson/Prentice Hall.
Online Resources
American Cancer Society. Cancer Facts and Figures 2013 . Atlanta, Ga: American Cancer
Society; 2013.
Breastcancer.org 7 East Lancaster Avenue. 3 rd Floor Ardmore. PA 19003 2013
Breastcancer.org- All rights reserved. Last modified on May 5, 2013 at 4:54 pm
http://www.breastcancer.org/symptoms/understand_bc .
GMA Network News Story retrieved from
http://www.gmanetwork.com/news/story/329126/cbb/phl-has-highest-breast-cancer-
rate-in-asia .
http://www.breastcancer.org/symptoms/understand_bchttp://www.breastcancer.org/symptoms/understand_bchttp://www.gmanetwork.com/news/story/329126/cbb/phl-has-highest-breast-cancer-rate-in-asiahttp://www.gmanetwork.com/news/story/329126/cbb/phl-has-highest-breast-cancer-rate-in-asiahttp://www.gmanetwork.com/news/story/329126/cbb/phl-has-highest-breast-cancer-rate-in-asiahttp://www.gmanetwork.com/news/story/329126/cbb/phl-has-highest-breast-cancer-rate-in-asiahttp://www.gmanetwork.com/news/story/329126/cbb/phl-has-highest-breast-cancer-rate-in-asiahttp://www.breastcancer.org/symptoms/understand_bc